DiRaimondo Thomas (0002005618)

Mailing Address C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200 SAN DIEGO CA 92130 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Janux Therapeutics, Inc. 0001817713 2024-01-01 officer: Chief Scientific Officer

Items 1 - 11

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
A	2025-01-02		Janux Therapeutics, Inc.	4	A-Award	--D	24000.0000	129719.0000	1	0001817713	Common Stock
A	2025-01-02		Janux Therapeutics, Inc.	4	A-Award	--D	84000.0000	84000.0000	2	0001817713	Stock option (right to buy)
D	2024-09-27		Janux Therapeutics, Inc.	4	S-Sale	--D	4325.0000	98613.0000	1	0001817713	Common Stock
D	2024-09-27		Janux Therapeutics, Inc.	4	S-Sale	--D	675.0000	97938.0000	2	0001817713	Common Stock
A	2024-01-02		Janux Therapeutics, Inc.	4	A-Award	--D	147000.0000	147000.0000	1	0001817713	Stock Option (right to buy)
-	-		Janux Therapeutics, Inc.	3	-	--D		101532.0000	1	0001817713	Common Stock
-	-		Janux Therapeutics, Inc.	3	-	--D			2	0001817713	Stock option (right to buy)
-	-		Janux Therapeutics, Inc.	3	-	--D			3	0001817713	Stock option (right to buy)
-	-		Janux Therapeutics, Inc.	3	-	--D			4	0001817713	Stock option (right to buy)
-	-		Janux Therapeutics, Inc.	3	-	--D			5	0001817713	Stock option (right to buy)
-	-		Janux Therapeutics, Inc.	3	-	--D			6	0001817713	Stock option (right to buy)

http://www.sec.gov/cgi-bin/own-disp

---